IL18 and macrophage activation syndrome: The role of free IL-18 levels in triggering MAS, combined with improvements in genetic testing and a growing number of targeted anti-cytokine therapies have revolutionized the diagnosis and management of autoinflammatory diseases in recent years and spearhead precision medicine in diagnosis and treatment in inflammatory and a wider spectrum of non-inflammatory diseases.